Abstracts

Probiotics Module Th1/Th17 and IFN Response in HIV Patients on Suppressive cART

The gut-associated lymphoid tissue (GALT) is an important site of HIV replication and immune dysfunction; previous works have demonstrated the failure of antiretroviral therapy (ART) in controlling the immune activation and modifying the balance of immune cells profiling in intestinal mucosa; we evaluated the immunomodulatory effect of six-month of probiotics supplementation in ART experienced subjects.…

Cenicriviroc Decreases sCD14 and LBP Levels Without Affecting Gut Permeability

Cenicriviroc (CVC), a potent oral, once-daily CCR2/CCR5 antagonist, blocks HIV entry through CCR5 blockade and inhibits monocyte trafficking through CCR2. Monocyte recruitment promotes atherosclerosis, hepatic fibrosis and other end-organ diseases in HIV infection. In a completed randomized, double-blind study of 48 weeks of CVC or efavirenz (EFV) with tenofovir/emtricitabine (TDF/FTC) (Study 652-2-202; NCT01338883), levels of…

Narrowing the Gap in Life Expectancy for HIV+ Compared With HIV- Individuals

Survival of HIV-infected individuals has dramatically improved with combination antiretroviral therapy (ART). However, it is unclear how large a gap in life expectancy remains between HIV-infected and HIV-uninfected individuals, and how much of that gap is attributable to underlying differences in demographics or risk factors. We conducted a cohort study of HIV-infected adults who were…

Perception of Infectiousness in HIV-Infected Persons After Initiating ART: ACTG A5257

Antiretroviral therapy (ART)-induced viral suppression has been shown to reduce sexual transmission of HIV. Data for prevention of HIV transmission are strongest for heterosexual transmission. ART does not produce immediate or universal viral suppression, and perception of infectiousness (POI) may impact sexual risk taking. Changes in POI as a result of ART may have implications…

Breast Milk and In Utero HIV-1 Transmission Select for Unique Envelope Signatures

Despite improved prevention of mother-to-child transmission (MTCT) of human immunodeficiency virus-type 1 (HIV-1) in developing countries, 240,000 children acquired the virus in 2013.  HIV-1 MTCT can occur by three distinct routes:  in utero (transplacental passage), intrapartum, and postpartum through breastfeeding.  Disease progression can vary dramatically among these transmission modes, with infants infected in utero showing…

Impact of Option B+ on ART Uptake and Retention in Swaziland: A Stepped-Wedge Trial

Retaining HIV-infected pregnant and postpartum women in care is critical to prevent mother-to-child HIV transmission (PMTCT) and promote maternal health. New PMTCT approaches call for lifelong antiretroviral therapy (ART) for all HIV+ pregnant women (Option B+), a departure from strategies that used CD4 count to determine ART eligibility (Option A). Yet there are few implementation…